Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2005
04/14/2005CA2541014A1 Spirocyclic heterocyclic derivatives and methods of their use
04/14/2005CA2540640A1 Vanilloid receptor ligands and their use in treatments
04/14/2005CA2539748A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
04/14/2005CA2537486A1 4-piridinylmethylsulphonamide derivatives as fungicidal plant protection agents
04/13/2005EP1522540A1 Azaarene derivatives
04/13/2005EP1521808A1 Compositions and inks containing disazo dyes
04/13/2005EP1521747A2 Receptor-type kinase modulators and methods of use
04/13/2005EP1521582A1 2,5-substituted pyrimidine derivatives as ccr-3 receptor antagonists
04/13/2005EP1289955B1 Piperidines for use as orexin receptor antagonists
04/13/2005EP1073640B1 Naphthalene derivatives, their production and use
04/13/2005EP0880507B1 Quinazoline derivatives as antitumor agents
04/13/2005CN1606592A Novel flame retarding compounds
04/13/2005CN1606554A Beta-lactamyl vasopressin v1aantagonists
04/13/2005CN1606553A Oxytocin agonistenoxytocin agonisten
04/13/2005CN1606547A 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
04/13/2005CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists
04/13/2005CN1606544A Bicyclic compound
04/13/2005CN1606443A Substituted diketopiperazines as oxytocin antagonists
04/13/2005CN1606439A Cis-imidazolines
04/13/2005CN1196697C Thiophene-ethyl thiourea compounds and their use in treatment of HIV
04/13/2005CN1196692C Substituted benzopyran derivatives for the treatment of inflammation
04/13/2005CN1196685C Pyrimidine derivatives
04/13/2005CN1196683C Amino-compound
04/13/2005CN1196497C Near infrared fluorescent contrast agent and fluorescence imaging
04/12/2005US6878743 Controlling apoptosis; central nervous system disorders
04/12/2005US6878736 Histamine H3 receptor ligands
04/12/2005US6878735 Multi-substituted imidazolines and method of use thereof
04/12/2005US6878730 Especially (2R)-N-(1-(6-aminopyridin-2-ylmethyl)1-methyl-piperdin-4-yl)-2-((1R)-3,3, -difluorocyclopentyl)-2-hydroxy-2-phenylacetamide iodide; treating asthma, chronic obstructive pulmonary disorder and allergic or infectious rhinitis
04/12/2005US6878729 Antihypoxic agents
04/12/2005US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals
04/12/2005US6878725 Serine protease inhibitors
04/12/2005US6878724 Polyarylcarboxamides useful as lipid lowering agents
04/12/2005US6878722 Substituted cycloalkyl P1′ hepatitis C virus inhibitors
04/12/2005US6878720 VEGF receptor tyrosine kinase inhibitors
04/12/2005US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
04/12/2005US6878717 HIV replication inhibiting pyrimidines
04/12/2005US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer
04/12/2005US6878713 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
04/12/2005US6878709 Treating acute and chronic inflammatory disorders and cancer.
04/12/2005US6878704 Heterocyclic mutilin esters and their use as antibacterials
04/12/2005US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
04/12/2005US6878697 Containing one or more phosphorus-containing moieties; treating bone disorders
04/12/2005CA2203936C Boronic ester and acid compounds, synthesis and uses
04/12/2005CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist
04/12/2005CA2122571C Adhesion receptor antagonists
04/12/2005CA2081836C Aromatic amidine derivatives and salts thereof
04/07/2005WO2005030979A2 Dark quenchers for fluorescence resonance energy transfer (fret) in bioassays
04/07/2005WO2005030796A1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
04/07/2005WO2005030794A2 Hemiasterlin derivatives and uses thereof
04/07/2005WO2005030782A2 Carbene ligands and their use
04/07/2005WO2005030765A1 Quinazoline derivatives as antiproliferative agents
04/07/2005WO2005030762A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030761A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2005WO2005030758A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof
04/07/2005WO2005030757A1 Quinazoline derivatives
04/07/2005WO2005030755A1 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
04/07/2005WO2005030754A1 Indole or quinoline derivatives as non-pepticid npy y2 receptor inhibitors useful for the treatment of anxiolytic and depressive disorders and obesity
04/07/2005WO2005030753A2 Therapeutic agents useful for treating pain
04/07/2005WO2005030751A2 Dipeptidyl peptidase inhibitors
04/07/2005WO2005030737A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
04/07/2005WO2005030735A1 Triazines derivatives as cell adhesion inhibitors
04/07/2005WO2005030733A1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
04/07/2005WO2005030729A1 Isoquinoline potassium channel inhibitors
04/07/2005WO2005030727A1 Isoquinolinone potassium channel inhibitors
04/07/2005WO2005030726A1 Isoquinolinone potassium channel inhibitors
04/07/2005WO2005030725A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
04/07/2005WO2005030715A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors
04/07/2005WO2005030216A1 5-arylpyrimidines as anticancer agents
04/07/2005WO2005030212A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors
04/07/2005WO2005030209A1 Pyridine derivatives and use thereof as urotensin ii antagonists
04/07/2005WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity
04/07/2005WO2005030151A2 Compounds and compositions as protein kinase inhibitors
04/07/2005WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections
04/07/2005WO2005030130A2 Isoquinoline potassium channel inhibitors
04/07/2005WO2005019147A3 Pesticidally active phenol derivatives
04/07/2005WO2005016918A3 Heterocyclic n-aryl carboxamides as cytokine inhibitors
04/07/2005WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
04/07/2005WO2005007647A9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/07/2005WO2004113286A3 Mucin synthesis inhibitors
04/07/2005WO2004112719A3 Chemical compounds
04/07/2005WO2004112709A3 Inhibitors of cathepsin s
04/07/2005WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds
04/07/2005WO2004048922A3 Bead-based detection of ligand-gpcr-g protein complexes
04/07/2005WO2004014871A8 Vanilloid receptor ligands and their use in treatments
04/07/2005US20050075507 1,2,4-Triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
04/07/2005US20050075384 Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
04/07/2005US20050075378 Modulators of peroxisome proliferator activated receptors (ppar)
04/07/2005US20050075375 Drugs as viricides for hepatitis C with carriers
04/07/2005US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
04/07/2005US20050075373 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
04/07/2005US20050075372 Method for controlling particular insect pest by applying anthranilamide compounds
04/07/2005US20050075370 Mixing chlorine, oxidant, thioether with the oxidant being sodium hypochlorite and alkali metal base. Recovering a sulfoxide such as chlorinated pantoprazole and sodium hydroxide for a sodium salt of sulfoxide
04/07/2005US20050075369 Novel form of S-omeprazole
04/07/2005US20050075366 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors
04/07/2005US20050075364 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
04/07/2005US20050075357 5-arylpyrimidines as anticancer agents
04/07/2005US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS
04/07/2005US20050075355 Brain, psychological, nervous system, respiratory sytem, gastrointestinal, autoimmune, eating, skin, cardiovascular, urogenital, neurodegenerative, and vision disorders; opioid receptor-like 1 agonists; drug abuse; bioavailability; cross blood-brain barrier
04/07/2005US20050075354 Anticarcinogenic and antiproliferative agents; diseases caused by overexpression of erbB2
04/07/2005US20050075353 Quinazolines and therapeutic use thereof
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 1080